Economics of myocardial perfusion imaging in Europe - The EMPIRE study

Keyphrases

• Europe 100%
• Empire 100%
• Myocardial Perfusion Imaging 100%
• Coronary Artery Disease 70%
• Coronary Angiography 40%
• Cost-effectiveness 20%
• Angiography 20%
• Diagnostic Strategy 20%
• Exercise Electrocardiogram 20%
• Prognostic Power 20%
• Germany 10%
• Patient Outcomes 10%
• Clinical Management 10%
• Clinical Outcomes 10%
• Primary Outcome Measure 10%
• Diagnostic Test 10%
• Clinical Data 10%
• France 10%
• United Kingdom 10%
• Working Diagnosis 10%
• Clinical Diagnosis 10%
• Diagnostic Accuracy 10%
• Computer Model 10%
• Cardiac Events 10%
• Normal Coronary Angiography 10%
• Arterial Disease 10%
• Italy 10%
• Diagnostic Costs 10%
• Pre-test Probability 10%
• Cost-effective Strategy 10%
• Regular Users 10%
• Management Outcome 10%
• Presentation Management 10%
• Complication Management 10%
• Management Costs 10%
• Clinical Patients 10%
• Revascularization 10%
• Investigation Strategies 10%

Medicine and Dentistry

• Myocardial Perfusion Imaging 100%
• Health Care Cost 80%
• Coronary Artery Disease 70%
• Coronary Angiography 50%
• Diagnosis 40%
• Cost-Effectiveness Analysis 20%
• Exercise Electrocardiography 20%
• Angiography 20%
• Diagnostic Test 10%
• Artery Disease 10%
• Clinical Management 10%
• Revascularization 10%

Nursing and Health Professions

• Myocardial Perfusion Imaging 100%
• Coronary Artery Disease 70%
• Coronary Angiography 50%
• Diagnosis 40%
• Cost Effectiveness Analysis 20%
• Exercise Electrocardiography 20%
• Angiography 20%
• Treatment Outcome 10%
• Clinical Management 10%
• Clinical Outcome 10%
• Cardiac Event 10%
• Diagnostic Test 10%
• Artery Disease 10%
• Revascularization 10%